Ultragenyx Pharmaceutical reported $-136632000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -113.02M 68.36M
Agios Pharmaceuticals AGIO:US $ -98.44M 3.74M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Aptinyx Inc APTX:US $ -19379000 207K
Biocryst Pharmaceuticals BCRX:US $ -49.96M 53.62M
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Bluebird Bio BLUE:US $ -120.35M 15.32M
Epizyme EPZM:US $ -50926000 360K
Esperion Therapeutics ESPR:US $ -42989000 12.64M
Insmed INSM:US $ -89833000 9.24M
IONIS PHARMACEUT IONS:US $ -57.5M 278.11M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Kyowa Hakko Kirin 4151:JP Y 17546M 727M
Mirati Therapeutics MRTX:US $ -184.22M 12.86M
Moderna Inc MRNA:US 4.23B 1.18B
Ptc Therapeutics PTCT:US $ -86.52M 1.79M
Puma Biotechnology PBYI:US $ -0.76M 7.79M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Ultragenyx Pharmaceutical RARE:US $ -136.63M 34.07M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
Vital Therapies VTL:US $ -21.44M 0.29M
Xoma XOMA:US $ -2065000 32.43M